1.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

2.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

3.

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective...

1.

Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.

2.

Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.

3.

Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.

1.

Penser le vieillissement de la population pour la Wallonie de demain

1.

Mental Health Conditions and Medical and Surgical Hospital Utilization

1.

Long-term exposure to fine particulate matter, lung function and cognitive performance: A prospective Dutch cohort study on the underlying routes.

1.

Evaluation économique de la campagne de dépistage de l'ostéoporose menée en Province de Liège avec le concours de Liège Province Santé ; Economic evaluation of osteoporosis screeni...

1.

Institutionnalisation d'un entretien prénatal : recherche action et intelligence collective

2.

Institutionnalisation d'un entretien prénatal : recherche action et intelligence collective

3.

Institutionnalisation d'un entretien prénatal : recherche action et intelligence collective

1.

La sitagliptine dans le traitement du diabete de type 2: le point, cinq ans apres sa commercialisation. ; Sitagliptin in the treatment of type 2 diabetes: insights five years after...

1.

Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study

2.

Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study

3.

Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study

4.

Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study

5.

Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study

1.

Utiliser une recherche-action comme étape d'une innovation

2.

Utiliser une recherche-action comme étape d'une innovation

3.

Utiliser une recherche-action comme étape d'une innovation